Associations of DMT therapies with COVID-19 severity in multiple sclerosis
Steve Simpson(University of Tasmania), Liesbet M. Peeters(Hasselt University), Tim Spelman(Peter Doherty Institute), Lotte Geys(Hasselt University), Edward De Brouwer(KU Leuven), Richard Nicholas(Swansea University), Nick Rijke(Multiple Sclerosis International Federation), Ricardo Alonso(Hospital Ramos Mejía), Amber Salter(Salter School), Tomáš Kalinčík(The Royal Melbourne Hospital), Helmut Butzkueven(Monash Alfred Psychiatry Research centre), Robert J. Fox(Cleveland Clinic), Yves Moreau(Dynamic Systems (United States)), Anneke van der Walt(The Alfred Hospital), Juan Ignacio Rojas(Hospital Universitario Austral), Gıancarlo Comı(Vita-Salute San Raffaele University), Clare Walton(Multiple Sclerosis International Federation), Alexander Stahmann(Unknown), R Ivanov, Amin Ardeshirdavani(KU Leuven), María Fernanda Mendes(Irmandade da Santa Casa de Misericórdia de São Paulo), Aníbal Chertcoff(Hospital Británico de Buenos Aires), Raed Alroughani(Amiri Hospital), Robert McBurney(Accelerated Cure Project for Multiple Sclerosis), Nikola Lazovski, Jan Hillert, Ana Zabalza(Universitat Autònoma de Barcelona), Ashkan Pirmani(Hasselt University), Alice Estavo Dias(Brazilian Medical Association), Ingrid van der Mei(University of Tasmania), Alexander Fidao(The University of Melbourne), Tina Parciak(Universitätsmedizin Göttingen), Doralina Guimarães Brum(National Cancer Center), Georgina Arrambide(Universitat Autònoma de Barcelona), Nupur Nag(Mental Health Research Institute), Clément Gautrais(KU Leuven), Gilles Edan(Centre National de la Recherche Scientifique), Guilherme Sciascia do Olival(Brazilian Medical Association), Johana Bauer, Serkan Özakbaş(İzmir University of Economics), Hollie Schmidt(Research Network (United States)), Stefan Braune, Lars Forsberg, Anna Glaser(Karolinska Institutet), Rod Middleton(Swansea University), Arnfin Bergmann, Melinda Magyari(University of Copenhagen)
Cited by 28
Related Papers
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k